Abstract:Background: Although chemotherapy represents a predominant anti-cancer therapeutic modality, drug treatment efficacy is often limited due to the development of resistant tumor cells. The pregnane X receptor (PXR) affects chemotherapeutic effects by regulating targets involved in drug metabolism and transportation, but the regulatory mechanism is poorly understood.Methods: Oxaliplatin (L-OHP) content in tumor cells was analyzed by mass cytometry. The roles of PXR on cancer cell proliferation, apoptosis and tumor growth with L-OHP-treated were investigated by MTS, colony formation, flow cytometry and xenograft tumor assays. Luciferase reporter, Chromatin-immunoprecipitation and Site-directed mutagenesis were evaluated the mechanisms. The PXR and multidrug resistance-related protein 3 (MRP3) expressions were examined by western blot, RT-PCR or immunohistochemistry of TMA. Kaplan-Meier and Cox regression were adopted to analyze the prognostic value of PXR in colorectal cancer (CRC).Results: PXR over-expression significantly increased oxaliplatin (L-OHP) transport capacity with a reduction of its content and repressed the effects of L-OHP on tumour cell proliferation and apoptosis. Conversely, PXR knockdown augments L-OHP-mediated cellular proliferation and apoptosis. Moreover, PXR significantly reduced the therapeutic effects of L-OHP on tumor growth in nude mice. Further studies indicated a positive correlation between PXR and MRP3 expression and this finding was confirmed in two independent cohorts. Significantly increased MRP3 expression was also found in PXR over-expressing cell lines. Mechanistically, PXR could directly bind to the MRP3 promoter, activating its transcription. The PXR binding sites were determined to be at-796 to-782bp (CTGAAGCAGAGGGAA) and the key binding sites were the "AGGGA" (-787 to-783bp) on the MRP3 promoter. Accordingly, blockade of MRP3 diminishes the effects on drug resistance of PXR. In addition, PXR expression is significantly associated with poor overall survival and represents an unfavorable and independent factor for male or stage I + II CRC patient prognosis.Conclusions: PXR is a potential biomarker for predicting outcome and activates MRP3 transcription by directly binding to its promoter resulting in an increased L-OHP efflux capacity, and resistance to L-OHP or platinum drugs in CRC. Our work reveals a novel and unique mechanism of drug resistance in CRC.

Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (atra) Metabolism and Its Potential Contribution to Atra Resistance

Role of the Pregnane X Receptor in the Clinical Resistance to All‐trans Retinoic Acid

Regulation of drug resistance by human pregnane X receptor in breast cancer.

Identification of Retinoic Acid As an Inhibitor of Transcription Factor Nrf2 Through Activation of Retinoic Acid Receptor Alpha

Pregnane X receptor as a therapeutic target to inhibit androgen activity.

The transcriptional regulation of drug enzymes and transporters mediated by Pregnane X receptor and its significant role in multidrug resistance

Distinct Role and Functional Mode of TR3 and RARα in Mediating ATRA-induced Signalling Pathway in Breast and Gastric Cancer Cells

Role of pregnane X receptor in chemotherapeutic treatment

Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ

Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3

Pregnane X Receptor is Associated with Unfavorable Survival and Induces Chemotherapeutic Resistance by Transcriptional Activating Multidrug Resistance-Related Protein 3 in Colorectal Cancer.

Metabolomics reveals dysregulated all-trans retinoic acid and polyunsaturated fatty acid metabolism contribute to PXR-induced hepatic steatosis in mice

THE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENES

Insights into the critical role of the PXR in preventing carcinogenesis and chemotherapeutic drug resistance

Xenobiotic Receptors Car and Pxr

Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter

First-in-Class Small Molecule Degrader of Pregnane X Receptor Enhances Chemotherapy Efficacy

Pregnane X Receptor Regulates the AhR/Cyp1A1 Pathway and Protects Liver Cells from Benzo-[Α]-pyrene-induced DNA Damage.

Dietary phytochemicals as modulators of human pregnane X receptor

All-trans Retinoic Acid is Capable of Inducing Folate Receptor Β Expression in KG-1 Cells

Association of Pregnane X Receptor with Multidrug Resistance-Related Protein 3 and Its Role in Human Colon Cancer Chemoresistance